Drug Policy Alliance Logo
About Take Action News Publications and Library Blog Contact Donate Events Community eStore
Home > News > L.A. Hepatitis C Summit Promotes Reliable Syringe Access for the First Time

News News


NYAM Right Side button

Conference 2009

Marijuana: The Facts
What's Wrong With the Drug War?
Safety First: Parents, Teens and Drugs
Drug By Drug
State By State
Reducing Harm: Treatment and Beyond
Drugs, Police & the Law
Communities Affected
Drug Policy Around the World
Publications and Library
What People are Talking About

Your Email
> Manage Subscriptions
What People are Talking About

Join the Drug Policy Alliance Network's work to promote drug policies based on science, compassion, health, and human rights.
Donate
> Get Involved
In this Section
bottom
The Latest

Cut Those Stupid TV Ads



Send A Message
Full Text Resources

> more

Featured News

In San Francisco, Where Flower Power Still Blooms-- New York Times (NY) [01/08/09]

> more news

 

Suggested Web sites
> more links

  

L.A. Hepatitis C Summit Promotes Reliable Syringe Access for the First Time
Tuesday, November 20, 2007

At the Fifth Annual Hepatitis C Summit last week in Los Angeles, DPA raised awareness of the Disease Prevention Demonstration Project (DPDP), a program allowing over-the-counter syringe sales in registered pharmacies in Los Angeles County (and several other counties around the state).

The DPDP was created by statewide legislation in 2004, and DPA supports implementation of the program in Los Angeles County.

Access to sterile syringes reduces the spread of blood-borne diseases such as HIV and hepatitis C among injection drug users, including those who inject intoxicants, as well as those with diabetes who inject insulin or those with hepatitis C who inject Interferon. When people use sterile syringes to inject, they not only protect themselves, but also their sexual partners and children. Right now, approximately 250 Los Angeles pharmacies are enrolled, or are in the process of enrolling, in the program, including two large pharmacy chains.

Meghan Ralston, DPA's harm reduction coordinator, and pharmacist Terry Hair presented on the program to a full room at the summit. A significant portion of the audience was people who work with injection drug users, some of whom later asked Ralston to present on the program at their facilities. Several audience members also said they would encourage their own pharmacies to enroll.

DPA staff also met with attendees one-on-one throughout the summit, educating more than 200 people about pharmacy syringe sales, handing out hundreds of educational pamphlets, and formally announcing the program's brand new hotline (1 866 96 4 No Rx).

The event received media attention from such diverse sources as the local NBC affiliate, Univision, Chinese Daily News and a local Korean-language paper.

The Hepatitis C Task Force hosts the summit every year, but this was the first summit to include formal discussion of reliable syringe access for injection drug users. Raising awareness of the DPDP and how it could impact hepatitis C transmission was an important step for disease prevention in Los Angeles.



Provide Feedback on this Page:

* 1.




 2.



 3.



   Please leave this field empty